Blood test could unlock cancer secrets for thousands of patients
NCT ID NCT04530890
First seen Jan 07, 2026 · Last updated May 16, 2026 · Updated 15 times
Summary
This study is collecting blood samples from 1,000 people with digestive, gynecologic, or breast cancer to study tiny bits of tumor DNA and particles called exosomes floating in the blood. Researchers want to see if these markers can help predict how the cancer will behave, whether treatments are working, and if the cancer is coming back. Participants give blood at several time points during their standard cancer care, and the results may lead to better, less invasive ways to monitor cancer in the future.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CHU POitiers
RECRUITINGPoitiers, France
Contact
Conditions
Explore the condition pages connected to this study.